Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives
Ayse Ceren Kaypak, Amir Raz
Transcultural Psychiatry August 29, 2022 DOI: 10.1177/13634615221119386 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | LSD Psilocybin Microdosing |
| Keywords | Hallucinogen Context archaeology Cognition Intervention counseling Psychotherapist |
| Citations | 17 |
| Key findings | Microdosing is a nascent practice with potential therapeutic and enhancement benefits, but its effects remain mostly unexplored in formal research. |
Abstract
To date, the clinical and scientific literature has best documented the effects of classical psychedelics, such as lysergic acid diethylamide (LSD), psilocybin, and dimethyltryptamine (DMT), in typical quantities most often associated with macrodosing. More recently, however, microdosing with psychedelics has emerged as a social trend and nascent therapeutic intervention. This variation in psychedelic practice refers to repeat, intermittent ingestion of less-than-macrodose amounts that do not cause the effects associated with full-blown “trips”. Microdosing paves the road to incorporating psychedelic drugs into a daily routine while maintaining, or even improving, cognitive and mental function. Unlike macrodosing with psychedelics, the influence of microdosing remains mostly unexplored. And yet, despite the paucity of formal studies, many informal accounts propose that microdosing plays an important role as both a therapeutic intervention (e.g., in mental disorders) and enhancement tool (e.g., recreationally—to boost creativity, improve cognition, and drive personal growth). In response to this relatively new practice, we provide an integrative synthesis of the clinical, social, and cultural dimensions of microdosing. We describe some of the overarching context that explains why this practice is increasingly in vogue, unpack potential benefits and risks, and comment on sociocultural implications. In addition, this article considers the effects that macro- and microdoses have on behavior and psychopathology in light of their dosage characteristics and contexts of use.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
Argues that microdosing is a nascent practice with potential therapeutic and enhancement benefits, but its effects remain mostly unexplored in formal research.
Synthesized
Comparable studies
Other narrative reviews on LSD and microdosing, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| The risk of chronic psychedelic and MDMA microdosing for valvular heart disease | 2023 | Review | |
| Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research | 2024 | Rapid review | n = 19 |
| Side effects of microdosing lysergic acid diethylamide and psilocybin: A systematic review of potential physiological and psychiatric outcomes | 2025 | Review | |
| Microdosing Psychedelics to Restore Synaptic Density in Schizophrenia. | 2025 | Review | |
| Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence Self-medicating individuals | 2026 | Scoping review |